These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33114107)

  • 21. RNAi as a tool to control the sex ratio of mouse offspring by interrupting Zfx/Zfy genes in the testis.
    Zhang Y; Xi J; Jia B; Wang X; Wang X; Li C; Li Y; Zeng X; Ying R; Li X; Jiang S; Yuan F
    Mamm Genome; 2017 Apr; 28(3-4):100-105. PubMed ID: 28251288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel.
    He W; Sun Z; Liu Z
    Exp Ther Med; 2015 Oct; 10(4):1413-1418. PubMed ID: 26622499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of RCK/p54 expression by RNAi inhibits proliferation of human colorectal cancer cells in vitro and in vivo.
    Lin F; Wang R; Shen JJ; Wang X; Gao P; Dong K; Zhang HZ
    Cancer Biol Ther; 2008 Oct; 7(10):1669-76. PubMed ID: 18769115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules.
    Alaaeldin E; Abu Lila AS; Ando H; Fukushima M; Huang CL; Wada H; Sarhan HA; Khaled KA; Ishida T
    J Control Release; 2017 Jun; 255():210-217. PubMed ID: 28461099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of combination of short hairpin RNA segments for silencing VEGF, TERT and Bcl-xl expression in laryngeal squamous carcinoma.
    Wang Y; Tao ZZ; Chen SM; Xiao BK; Zhou XH; Liu JP
    Cancer Biol Ther; 2008 Jun; 7(6):896-901. PubMed ID: 18367874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
    Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic delivery of Eg5 shRNA-expressing plasmids using PEGylated DC-Chol/DOPE cationic liposome: Long-term silencing and anticancer effects in vivo.
    Seraj S; Lee J; Ahn HJ
    Biochem Pharmacol; 2019 Aug; 166():192-202. PubMed ID: 31129050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The study in lasting effectivity on conditionally replicating adenovirus shRNA mediating survivin gene silencing in colon carcinoma cell line HT-29].
    Wang CY; Fu ZX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):924-8. PubMed ID: 18095587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-inducible bidirectional shRNA expression vector delivery using PEI/chitosan-TBA copolymers for colorectal Cancer gene therapy.
    Javan B; Atyabi F; Shahbazi M
    Life Sci; 2018 Jun; 202():140-151. PubMed ID: 29656061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A robust gene signature for the prediction of early relapse in stage I-III colon cancer.
    Dai W; Li Y; Mo S; Feng Y; Zhang L; Xu Y; Li Q; Cai G
    Mol Oncol; 2018 Apr; 12(4):463-475. PubMed ID: 29377588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
    Lin M; Hu J; Liu T; Li J; Chen B; Chen X
    Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. sgRNA-shRNA Structure Mediated SNP Site Editing on Porcine
    Sun Y; Yan N; Mu L; Sun B; Deng J; Fang Y; Shao S; Yan Q; Han F; Zhang Z; Xu K
    Front Genet; 2019; 10():347. PubMed ID: 31057603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CancerGD: A Resource for Identifying and Interpreting Genetic Dependencies in Cancer.
    Bridgett S; Campbell J; Lord CJ; Ryan CJ
    Cell Syst; 2017 Jul; 5(1):82-86.e3. PubMed ID: 28711281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study.
    Kuramochi H; Nakamura A; Nakajima G; Kaneko Y; Araida T; Yamamoto M; Hayashi K
    BMC Cancer; 2016 Jun; 16():366. PubMed ID: 27296289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor inhibition by genomically integrated inducible RNAi-cassettes.
    Kappel S; Matthess Y; Zimmer B; Kaufmann M; Strebhardt K
    Nucleic Acids Res; 2006; 34(16):4527-36. PubMed ID: 16945954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.
    Tew GW; Hackney JA; Gibbons D; Lamb CA; Luca D; Egen JG; Diehl L; Eastham Anderson J; Vermeire S; Mansfield JC; Feagan BG; Panes J; Baumgart DC; Schreiber S; Dotan I; Sandborn WJ; Kirby JA; Irving PM; De Hertogh G; Van Assche GA; Rutgeerts P; O'Byrne S; Hayday A; Keir ME
    Gastroenterology; 2016 Feb; 150(2):477-87.e9. PubMed ID: 26522261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects and mechanism of the circadian clock gene Per1 on the proliferation, apoptosis, cycle, and tumorigenicity in vivo of human oral squamous cell carcinoma].
    Xiaojuan F; Kai Y; Hanxue L; Qin Z; Dan C
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2016 Jun; 34(3):255-61. PubMed ID: 27526449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
    Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
    N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of endogenous multidrug resistance 1 and P-glycoprotein expression on anticancer drug resistance in colon cancer cell lines.
    Washio I; Nakanishi T; Ishiguro N; Bister B; Tamai I
    Biopharm Drug Dispos; 2019 Jan; 40(1):32-43. PubMed ID: 30556139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.